Cardiovascular and renal outcomes of GLP-1 receptor agonists vs. DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: A systematic review and meta-analysis.
Marc EvansPaul KuodiChisom Joyqueenet AkunnaNicole McCreedyMorten DonsmarkHongye RenChukwudi Arnest NnajiPublished in: Diabetes & vascular disease research (2023)
CRD42022335504.